ARROWHEAD PHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Arrowhead Pharmaceuticals, Inc. Current Ratio for the quarter ending June 30, 2024 was 497 %, a 2.68% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 497 +13 +2.68% Jun 30, 2024
Q1 2024 547 +130 +31.1% Mar 31, 2024
Q4 2023 520 +174 +50.1% Dec 31, 2023
Q3 2023 529 +236 +80.3% Sep 30, 2023
Q2 2023 484 +199 +69.5% Jun 30, 2023
Q1 2023 417 +148 +54.7% Mar 31, 2023
Q4 2022 347 +62.6 +22% Dec 31, 2022
Q3 2022 294 -47.4 -13.9% Sep 30, 2022
Q2 2022 286 -125 -30.4% Jun 30, 2022
Q1 2022 270 -292 -52% Mar 31, 2022
Q4 2021 284 -504 -64% Dec 31, 2021
Q3 2021 341 -353 -50.8% Sep 30, 2021
Q2 2021 411 -115 -21.9% Jun 30, 2021
Q1 2021 561 +133 +31.2% Mar 31, 2021
Q4 2020 788 +440 +126% Dec 31, 2020
Q3 2020 693 +457 +194% Sep 30, 2020
Q2 2020 526 +285 +119% Jun 30, 2020
Q1 2020 428 +184 +75.4% Mar 31, 2020
Q4 2019 348 +52.8 +17.9% Dec 31, 2019
Q3 2019 236 -440 -65.1% Sep 30, 2019
Q2 2019 240 -326 -57.5% Jun 30, 2019
Q1 2019 244 -227 -48.2% Mar 31, 2019
Q4 2018 295 -64 -17.8% Dec 31, 2018
Q3 2018 677 +347 +105% Sep 30, 2018
Q2 2018 566 +236 +71.7% Jun 30, 2018
Q1 2018 471 +151 +47.3% Mar 31, 2018
Q4 2017 359 +18.1 +5.3% Dec 31, 2017
Q3 2017 330 -102 -23.5% Sep 30, 2017
Q2 2017 330 -197 -37.4% Jun 30, 2017
Q1 2017 320 -386 -54.7% Mar 31, 2017
Q4 2016 341 -483 -58.6% Dec 31, 2016
Q3 2016 431 -506 -54% Sep 30, 2016
Q2 2016 527 -605 -53.5% Jun 30, 2016
Q1 2016 706 -567 -44.5% Mar 31, 2016
Q4 2015 824 -631 -43.4% Dec 31, 2015
Q3 2015 937 -468 -33.3% Sep 30, 2015
Q2 2015 1.13K -48.3 -4.09% Jun 30, 2015
Q1 2015 1.27K +409 +47.4% Mar 31, 2015
Q4 2014 1.46K +1K +221% Dec 31, 2014
Q3 2014 1.41K +1.15K +451% Sep 30, 2014
Q2 2014 1.18K +979 +487% Jun 30, 2014
Q1 2014 864 +773 +846% Mar 31, 2014
Q4 2013 454 +338 +292% Dec 31, 2013
Q3 2013 255 +120 +89.1% Sep 30, 2013
Q2 2013 201 +30.9 +18.2% Jun 30, 2013
Q1 2013 91.3 -124 -57.7% Mar 31, 2013
Q4 2012 116 Dec 31, 2012
Q3 2012 135 Sep 30, 2012
Q2 2012 170 Jun 30, 2012
Q1 2012 216 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.